<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Summit Hotel Properties Inc — News on 6ix</title>
    <link>https://6ix.com/company/summit-hotel-properties-inc</link>
    <description>Latest news and press releases for Summit Hotel Properties Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 23 Apr 2026 20:30:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/summit-hotel-properties-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683583f178dffbe2df0fce6d.webp</url>
      <title>Summit Hotel Properties Inc</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc</link>
    </image>
    <item>
      <title>SUMMIT HOTEL PROPERTIES DECLARES FIRST QUARTER 2026 DIVIDENDS</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-declares-first-quarter-2026-dividends</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-declares-first-quarter-2026-dividends</guid>
      <pubDate>Thu, 23 Apr 2026 20:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the first quarter ended March 31, 2026, of $0.08 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company&apos;s operating partnership. The Company&apos;s first quarter common dividend represents an annualized dividend yield of 6.8 percent based on the closing price of</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2026 EARNINGS RELEASE DATE</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-announces-first-quarter-2026-earnings-release-date</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-announces-first-quarter-2026-earnings-release-date</guid>
      <pubDate>Wed, 25 Mar 2026 20:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;) today announced that it will report financial results for the first quarter of 2026 on Thursday, April 30, 2026, after the market closes.</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-reports-fourth-quarter-and-full-year-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-reports-fourth-quarter-and-full-year-2025-results</guid>
      <pubDate>Wed, 25 Feb 2026 21:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;), today announced results for the three and twelve months ended December 31, 2025.</description>
    </item>
    <item>
      <title>Summit Hotel Properties Announces 2026 Annual Meeting of Stockholders</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-announces-2026-annual-meeting-of-stockholders</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-announces-2026-annual-meeting-of-stockholders</guid>
      <pubDate>Fri, 20 Feb 2026 21:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;) today announced that its 2026 Annual Meeting of Stockholders will be held Wednesday, May 20, 2026, beginning at 8:00 a.m. Central Time. The meeting will be held at the Hampton Inn &amp; Suites Austin Downtown located at 200 San Jacinto Boulevard, Austin, Texas 78701. The meeting is open to all stockholders of record as of March 6, 2026.</description>
    </item>
    <item>
      <title>Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-corporation-anticipates-listing-on-the-nyse-american-stock-exchange-with-concurrent-offering</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-corporation-anticipates-listing-on-the-nyse-american-stock-exchange-with-concurrent-offering</guid>
      <pubDate>Tue, 27 Jan 2026 21:00:00 GMT</pubDate>
      <description>Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the &quot;Company&quot; or &quot;Innocan&quot;), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that, further to its press release dated January 2, 2026, it now anticipates to list on NYSE American on or around January 30, 2026, subject to approval of its listing application and continued compliance with exchange rules.&quot; subject to authorization of the application and continu</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2025 DIVIDENDS</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-declares-fourth-213000274</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-declares-fourth-213000274</guid>
      <pubDate>Thu, 22 Jan 2026 21:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the fourth quarter ended December 31, 2025, of $0.08 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company&apos;s operating partnership. The Company&apos;s fourth quarter common dividend represents an annualized dividend yield of 6.6 percent based on the closing pri</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 EARNINGS RELEASE DATE</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-announces-fourth-220000009</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-announces-fourth-220000009</guid>
      <pubDate>Mon, 12 Jan 2026 22:00:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;) today announced that it will report financial results for the fourth quarter and full year of 2025 on Wednesday, February 25, 2026, after the market closes.</description>
    </item>
    <item>
      <title>Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-announces-public-filing-of-amended-registration-statement-for-proposed-us-public-offering</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-announces-public-filing-of-amended-registration-statement-for-proposed-us-public-offering</guid>
      <pubDate>Wed, 10 Dec 2025 15:40:00 GMT</pubDate>
      <description>Innocan Pharma Corporation (&quot;Innocan&quot; or the &quot;Company&quot;) (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed an amendment to its registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the &quot;SEC&quot;) relating to a proposed public offering of units (each, a &quot;Unit&quot; and collectively, the &quot;Units&quot;) in the United States. The original registration statement was filed on July 23, 2025.</description>
    </item>
    <item>
      <title>Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-reports-financial-results-for-q3-2025-with-revenues-at-us-dollar216m</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-reports-financial-results-for-q3-2025-with-revenues-at-us-dollar216m</guid>
      <pubDate>Thu, 27 Nov 2025 06:34:00 GMT</pubDate>
      <description>Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the &quot;Company&quot; or &quot;Innocan&quot;), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce its financial consolidated results for the nine months ended September 30, 2025 and provide a Company update.</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES PUBLISHES 2025 CORPORATE RESPONSIBILITY REPORT</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-publishes-2025-213000911</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-publishes-2025-213000911</guid>
      <pubDate>Tue, 11 Nov 2025 21:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;) today announced the publication of its annual Corporate Responsibility Report, which represents the Company&apos;s ongoing commitment to creating long-term shareholder value by investing responsibly, safeguarding the environment, and supporting its employees, communities, and other stakeholders.</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2025 RESULTS</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-reports-third-213700282</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-reports-third-213700282</guid>
      <pubDate>Tue, 04 Nov 2025 21:37:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;), today announced results for the three and nine months ended September 30, 2025.</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2025 DIVIDENDS</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-declares-third-210000432</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-declares-third-210000432</guid>
      <pubDate>Fri, 31 Oct 2025 21:00:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the third quarter ended September 30, 2025, of $0.08 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company&apos;s operating partnership. The Company&apos;s third quarter common dividend represents an annualized dividend yield of 6.1 percent based on the closing pric</description>
    </item>
    <item>
      <title>Innocan Pharma to Present at the 2025 ThinkEquity Conference</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-to-present-at-the-2025-thinkequity-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-to-present-at-the-2025-thinkequity-conference</guid>
      <pubDate>Fri, 24 Oct 2025 20:01:00 GMT</pubDate>
      <description>Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (&quot;Innocan&quot; or the &quot;Company&quot;), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that it will be participating in The ThinkEquity Conference, taking place October 30, 2025, at the Mandarin Oriental, New York City.</description>
    </item>
    <item>
      <title>Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/liposomal-cbd-injection-technology-lpt-cbd-patent-was-allowed-in-japan</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/liposomal-cbd-injection-technology-lpt-cbd-patent-was-allowed-in-japan</guid>
      <pubDate>Wed, 15 Oct 2025 20:00:00 GMT</pubDate>
      <description>Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (&quot;Innocan&quot; or the &quot;Company&quot;), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its patent for LPT-CBD was allowed in Japan and will be officially granted upon completion of the administrative process. The patent covers a prolonged-release liposome-based formulation that encapsulates cannabinoids.</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES ANNOUNCES THIRD QUARTER 2025 EARNINGS RELEASE DATE</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-announces-third-203000376</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-announces-third-203000376</guid>
      <pubDate>Tue, 23 Sep 2025 20:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;) today announced that it will report financial results for the third quarter of 2025 on Tuesday, November 4, 2025, after the market closes.</description>
    </item>
    <item>
      <title>Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-partners-with-a-sanctuary-for-injured-animals-to-bring-remedy-and-hope-with-its-lpt-cbd-injection</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-partners-with-a-sanctuary-for-injured-animals-to-bring-remedy-and-hope-with-its-lpt-cbd-injection</guid>
      <pubDate>Thu, 18 Sep 2025 20:00:00 GMT</pubDate>
      <description>Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (&quot;Innocan&quot; or the &quot;Company&quot;), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce its ongoing collaboration with Freedom Farm, a sanctuary dedicated to rescuing animals that were expelled from the industrial farms as a result of the animals having physical disabilities and other medical conditions. Through this collaboration, Freedom Farm animals that suffer from painful conditions receive compassio</description>
    </item>
    <item>
      <title>Innocan Pharma Announces Details of Proposed Share Consolidation</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-announces-details-of-proposed-share-consolidation</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-announces-details-of-proposed-share-consolidation</guid>
      <pubDate>Fri, 29 Aug 2025 20:00:00 GMT</pubDate>
      <description>Innocan Pharma Corporation (&quot;Innocan&quot; or the &quot;Company&quot;) (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release dated July 23, 2025, it will be consolidating all of its issued and outstanding common shares (&quot;Common Shares&quot;) on the basis of one (1) post-consolidation Common Share for each 65 pre-consolidation Common Shares (the &quot;Share Consolidation&quot;). The Share Consolidation represents another step towards the completion of a proposed public offering of unit</description>
    </item>
    <item>
      <title>Innocan Pharma Announces First Half Of 2025 Financial Results</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-announces-first-half-of-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/innocan-pharma-announces-first-half-of-2025-financial-results</guid>
      <pubDate>Wed, 27 Aug 2025 20:01:00 GMT</pubDate>
      <description>Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the &quot;Company&quot; or &quot;Innocan&quot;), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its financial consolidated results for the six months ended June 30, 2025. This period delivered a positive swing in Innocan&apos;s operating profitability together with continued strengthening of its balance sheet.</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES REPORTS SECOND QUARTER 2025 RESULTS</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-reports-second-203000360</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-reports-second-203000360</guid>
      <pubDate>Tue, 05 Aug 2025 20:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;), today announced results for the three and six months ended June 30, 2025.</description>
    </item>
    <item>
      <title>SUMMIT HOTEL PROPERTIES DECLARES SECOND QUARTER 2025 DIVIDENDS</title>
      <link>https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-declares-second-203000141</link>
      <guid isPermaLink="true">https://6ix.com/company/summit-hotel-properties-inc/news/summit-hotel-properties-declares-second-203000141</guid>
      <pubDate>Fri, 01 Aug 2025 20:30:00 GMT</pubDate>
      <description>Summit Hotel Properties, Inc. (NYSE: INN) (the &quot;Company&quot;), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the second quarter ended June 30, 2025, of $0.08 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company&apos;s operating partnership. The Company&apos;s second quarter common dividend represents an annualized dividend yield of 6.1 percent based on the closing price o</description>
    </item>
  </channel>
</rss>